New Edge Advisors, LLC Exelixis, Inc. Transaction History

New Edge Advisors, LLC

  • $15 Billion
  • Q3 2024

A detailed history of New Edge Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 13,051 shares of EXEL stock, worth $442,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,051
Previous 19,976 34.67%
Holding current value
$442,950
Previous $448,000 24.55%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$21.96 - $27.6 $152,073 - $191,130
-6,925 Reduced 34.67%
13,051 $338,000
Q2 2024

Aug 15, 2024
SELL
$20.34 - $23.73 $197,786 - $230,750
-9,724 Reduced 32.74%
19,976 $448,000
Q1 2024

May 14, 2024
BUY
$20.17 - $23.93 $32,856 - $38,981
1,629 Added 5.8%
29,700 $704,000
Q4 2023

Feb 13, 2024
BUY
$19.25 - $24.13 $167,552 - $210,027
8,704 Added 44.94%
28,071 $673,000
Q2 2023

Aug 14, 2023
BUY
$18.17 - $20.48 $206,538 - $232,796
11,367 Added 142.09%
19,367 $370,000
Q1 2023

May 12, 2023
SELL
$16.3 - $19.41 $10,725 - $12,771
-658 Reduced 7.6%
8,000 $155,000
Q4 2022

Feb 14, 2023
SELL
$14.96 - $17.39 $40,631 - $47,231
-2,716 Reduced 23.88%
8,658 $138,000
Q3 2022

Nov 14, 2022
BUY
$15.68 - $22.27 $178,344 - $253,298
11,374 New
11,374 $178,000
Q1 2021

Apr 26, 2021
SELL
$20.53 - $25.22 $285,202 - $350,356
-13,892 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$18.39 - $24.8 $50,590 - $68,224
2,751 Added 24.69%
13,892 $279,000
Q3 2020

Nov 03, 2020
SELL
$20.67 - $26.94 $149,650 - $195,045
-7,240 Reduced 39.39%
11,141 $272,000
Q2 2020

Jul 29, 2020
SELL
$16.46 - $27.42 $66,498 - $110,776
-4,040 Reduced 18.02%
18,381 $436,000
Q1 2020

May 04, 2020
BUY
$14.46 - $21.8 $52,648 - $79,373
3,641 Added 19.39%
22,421 $386,000
Q4 2019

Jan 31, 2020
BUY
$15.15 - $18.89 $8,923 - $11,126
589 Added 3.24%
18,780 $330,000
Q3 2019

Nov 06, 2019
SELL
$17.68 - $22.65 $1,785 - $2,287
-101 Reduced 0.55%
18,191 $322,000
Q2 2019

Aug 05, 2019
BUY
$18.93 - $24.75 $795 - $1,039
42 Added 0.23%
18,292 $391,000
Q1 2019

May 14, 2019
SELL
$19.6 - $24.76 $1.24 Million - $1.57 Million
-63,430 Reduced 77.66%
18,250 $434,000
Q1 2019

May 09, 2019
BUY
$19.6 - $24.76 $897,268 - $1.13 Million
45,779 Added 127.51%
81,680 $1.22 Million
Q4 2018

Jan 29, 2019
BUY
$13.65 - $21.8 $39,598 - $63,241
2,901 Added 8.79%
35,901 $706,000
Q1 2018

May 11, 2018
BUY
$22.15 - $31.89 $66,450 - $95,670
3,000 Added 10.0%
33,000 $709,000
Q2 2017

Aug 16, 2017
BUY
N/A
30,000
30,000 $0

Others Institutions Holding EXEL

# of Institutions
502
Shares Held
243M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email